VARSHA AGARWAL

EDUCATION

Bachelor of Dental Surgery, PGIDS, Rohtak
Master of Dental Surgery, PGIDS, Rohtak

RESEARCH, TEACHING, or OTHER INTERESTS

Dentistry, General Dentistry, Medicine

Scopus Publications

Rare Histologic Imitator Central Mucoepidermoid Carcinoma Arising from Glandular Odontogenic Cyst of the Mandible: Case Report with Updated Review of Literature
Anju Devi, Gitika Sharma, Mala Kamboj, Anjali Narwal, Varsha Agarwal
Indian Journal of Otolaryngology and Head and Neck Surgery, 2024
Local injection of amphotericin B: novel use in the treatment of fungal maxillary sinusitis
V. Agarwal, K. Kumia, A. Gupta, V. Singh
International Journal of Oral and Maxillofacial Surgery, 2023
Evaluation of risk factors, clinico-radiographic presentations of COVID-associated mucormycosis in the maxillofacial region reporting to a tertiary care dental facility
Varsha Agarwal, Ambika Gupta, Virendra Singh, Komal Kumia, Bhawna Saini, N. Suriya
Journal of Oral Biology and Craniofacial Research, 2023
Purpose: To evaluate the prevalence of risk factors associated with COVID-associated mucormycosis (CAM) in the maxillofacial region with emphasis on clinical and radiological characteristics of the disease reporting to the dentists. Methods: Archival records of the patients diagnosed with rhino-cerebral mucormycosis through histopathology or culture, were screened and 266 records were included. These records were divided into three groups-previously diabetic (PD, n = 122), recently diagnosed diabetic (RD, n = 105) and non-diabetic (ND, n = 39). All the records were evaluated and compared among the three groups for the duration of presentation, history of co-existing medical conditions, the association of treatment given during COVID-19, and the clinical and radiographic presentations of the disease. Results: The results confirmed uncontrolled diabetes mellitus as the major risk factor for the disease. The prevalence of steroid administration was lower in our study in contrast to previous literature. The risk factors and treatment rendered during COVID-19 did not differ significantly among the three groups (p > 0.05). The findings indicate that the disease was milder and progressed more slowly in the ND group, both clinically and radiographically, and it had close resemblance to odontogenic infection. Conclusion: Patients with early CAM mimicked the odontogenic infection and were more likely to report in a dental setup. Hence, a multidisciplinary and holistic management approach is necessary.
Mucormycosis infection associated with global COVID-19 pandemic-an institutional histopathological study
R. Keerthika, A. Narwal, M. Kamboj, A. Devi, R. Anand, S. N, V. Singh, V. Agarwal, A. Gupta
Medicina Oral Patologia Oral Y Cirugia Bucal, 2023
Background Coronavirus disease 2019 (COVID-19) in the recent times have instilled signs of immunosuppression globally which has further precipitated increasing range of opportunistic infections. Mucormycosis is a distressing opportunistic fungal infection with a high incidence and is the third commonest acute invasive infection following candidiasis and aspergillosis. The aim of the present observational study is to delineate the enigmatic histopathological profile between mucormycosis cases seen prior to pandemic (PPM) and pandemic associated mucormycosis (PAM). Material and Methods Tissue archives of 105 histopathologically diagnosed cases of mucormycosis were included and analysed for demographical details and histopathological parameters like fungal load and localization, granuloma formation, necrosis, inflammatory infiltrate and tissue invasion. Results 0ut of 105 included cases, 11/105 (10.48%) were reported PPM and 94/105 (89.52%) PAM. Among 94 cases of PAM, 51/94 (54%) cases also showed COVID-19 positivity, while 43/94 (46%) did not. Of all the histological variables, increased fungal load and necrosis were observed in PAM relative to PPM cases. Conclusions The histopathological variables like fungal load, necrosis, granuloma formation and tissue invasion, could help the clinician in assessing the clinical status at the time of tissue diagnosis and improve the treatment accordingly. Key words:COVID-19, fungal load, granuloma, mucormycosis, necrosis.
Are Low Serum Vitamin D Levels a Risk Factor for Advent of COVID-19 Associated Rhinocerebral Mucormycosis: A Preliminary Case Control Study
Harsha Popli, Ambika Gupta, Virendra Singh, Varsha Agarwal, R. Akilan, Adarsh Kumar
Indian Journal of Otolaryngology and Head and Neck Surgery, 2022
Association of COVID-19 with Rhino-Cerebral Mucormycosis: An Observational Study
Varsha Agarwal, Ambika Gupta, Virendra Singh, Neha Jajodia, Harsha Popli, R. Akilan
Journal of Maxillofacial and Oral Surgery, 2022
Comparative Efficacy of Platelet-Rich Plasma and Dry Needling for Management of Trigger Points in Masseter Muscle in Myofascial Pain Syndrome Patients: A Randomized Controlled Trial
Varsha Agarwal, Ambika Gupta, Harneet Singh, Mala Kamboj, Harsha Popli, Suman Saroha
Journal of Oral and Facial Pain and Headache, 2022
AIMS: To compare the efficacy of platelet-rich plasma (PRP) injection vs dry needling (DN) for management of trigger points in the masseter muscle in myofascial pain syndrome (MPS) patients. METHODS: This randomized controlled trial included 30 clinically confirmed cases of myofascial trigger points (MTrPs) in the masseter muscle who were randomly and equally (1:1) assigned to the test (PRP) and control (DN) groups. Both groups were evaluated for pain (visual analog scale [VAS]), range of functional movements, need for pain medication, patient satisfaction (Likert scale), and sleep (VAS) at baseline and 2-week, 1-month, and 3-month follow-ups. VAS pain and Likert score were also obtained at 6-month intervals. RESULTS: The use of PRP solution in MTrPs in MPS patients had a better effect on pain and patient satisfaction compared to DN. CONCLUSION: PRP appears to be a more effective treatment modality compared to DN in the management of MTrPs in MPS patients.